Cargando…
Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
BACKGROUND: The extracellular matrix (ECM) is essential for malignant tumour progression, as it is a physical barrier to various kinds of anticancer therapies. Matrix metalloproteinase (MMPs) can degrade almost all ECM components, and macrophages are an important source of MMPs. Studies using macrop...
Autores principales: | Zhang, Wenlong, Liu, Ling, Su, HuiFang, Liu, Qin, Shen, Jie, Dai, Hanren, Zheng, Wei, Lu, Yan, Zhang, Weijie, Bei, Yuncheng, Shen, Pingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889154/ https://www.ncbi.nlm.nih.gov/pubmed/31570753 http://dx.doi.org/10.1038/s41416-019-0578-3 |
Ejemplares similares
-
Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer
por: Dong, Xuhui, et al.
Publicado: (2023) -
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
por: Dai, Hanren, et al.
Publicado: (2016) -
Engineering chimeric antigen receptor T cells for solid tumour therapy
por: Liu, Longwei, et al.
Publicado: (2022) -
M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma
por: Shen, Long, et al.
Publicado: (2016) -
Linked in: the extracellular matrix network in tumour dissemination
por: Leb‐Reichl, V., et al.
Publicado: (2020)